Evaluation of Microhematuria: A Risk-based Approach - Frankly Speaking EP 199Guest: Alan Ehrlich MD, FAAFP
Music Credit: Richard Onorato
Microhematuria is a common finding. It is usually benign, but it needs proper evaluation since it may also be a sign of malignancy. A risk-based approach can avoid unnecessary testing, while still identifying those patients with malignancy. Recent American Urological Association (AUA) guidelines use a validated risk-based approach.
Already listened on another platform?
0 Credits - Not for CME/CE Credit
Release Date: 11/23/2020
Expiration Date: 11/23/2021
- Assess the risk for malignancy in patients with microhematuria
- Describe a risk-based approach to evaluating microhematuria
Frank J. Domino, MD
Professor, Family Medicine and Community Health,
University of Massachusetts Medical School, Worcester, MA
Alan M. Ehrlich, MD, FAAFP
Associate Professor of Family Medicine and Community Health, University of Massachusetts Medical School
Executive Editor, DynaMed
Supporters and Partners